The treatment at 8 hpi rather than at earlier time of infection was to reduce the impact of unphosphorylated 4E-BP1 on VACV replication as early treatment of cells with LY294002 could inhibit VACV replication [28]. The gene discussed is EIF4EBP1; the disease is infection.